Toujeo

Product manufactured by Sanofi-Aventis U.s. Llc

Application Nr Approved Date Route Status External Links
BLA206538 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Toujeo Is Indicated To Improve Glycemic Control In Adults And Pediatric Patients 6 Years Of Age And Older With Diabetes Mellitus. Toujeo Is A Long-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Adults And Pediatric Patients 6 Years And Older With Diabetes Mellitus. ( 1 ) Limitations Of Use : Not Recommended For Treating Diabetic Ketoacidosis. ( 1 ) Limitations Of Use : Toujeo Is Not Recommended For The Treatment Of Diabetic Ketoacidosis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Glargine

Comments